Strategic Partnerships Potential sales opportunities exist through expanding collaborations with biosensor and diagnostics players, leveraging General Graphene's proven track record with HeMemics and Graphenedx to accelerate adoption of graphene-based sensing and POC devices.

Scale & Roll-to-Roll Highlight the company’s industrial-scale CVD roll-to-roll graphene capabilities to attract high-volume manufacturers in sensors, flexible electronics, membranes, and energy storage, offering cost-effective, scalable graphene solutions.

Diverse Markets Target cross-market opportunities across healthcare, wearables, battery research, membranes, and flexible electronics by emphasizing a broad portfolio of CVD graphene films, 3D graphene foams, and pyrolytic carbon films.

Funding & Growth With substantial funding backing ($38M) but revenue under $1M, position General Graphene as a growth partner for strategic alliances and co-development programs that de-risk early-stage graphene applications for customers.

Intense Collaborations Leverage recent high-profile partnerships (Sapphiros UK, GrapheneDx) to demonstrate momentum and credibility in rapid deployment of graphene-based biosensors and high-volume manufacturing capabilities to potential enterprise clients.